IFP Advisors, Inc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2022$2
-99.9%
237
-5.2%
0.00%
Q3 2022$3,0000.0%2500.0%0.00%
Q2 2022$3,000
-40.0%
250
-37.5%
0.00%
Q1 2022$5,000
+400.0%
400
+1042.9%
0.00%
Q3 2021$1,0000.0%350.0%0.00%
Q2 2021$1,0000.0%350.0%0.00%
Q1 2021$1,0000.0%350.0%0.00%
Q4 2020$1,0000.0%350.0%0.00%
Q3 2020$1,0000.0%350.0%0.00%
Q2 2020$1,000
-50.0%
35
-45.3%
0.00%
Q1 2020$2,000640.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q1 2019$21,000
-43.2%
619
-43.6%
0.00%
+50.0%
Q4 2018$37,000
-78.1%
1,097
-60.5%
0.00%
-71.4%
Q3 2018$169,000
+108.6%
2,775
+67.8%
0.01%
+133.3%
Q2 2018$81,000
-19.8%
1,654
-2.4%
0.00%
-40.0%
Q1 2018$101,0000.0%1,6940.0%0.01%0.0%
Q4 2017$101,000
+152.5%
1,694
+0.5%
0.01%
+150.0%
Q3 2017$40,000
+21.2%
1,6860.0%0.00%
+100.0%
Q2 2017$33,000
-45.9%
1,686
-34.8%
0.00%
-66.7%
Q1 2017$61,000
+205.0%
2,586
+55.3%
0.00%
+200.0%
Q4 2016$20,000
-28.6%
1,665
+0.7%
0.00%0.0%
Q3 2016$28,000
+33.3%
1,653
+10.2%
0.00%0.0%
Q2 2016$21,0000.0%1,500
+142.3%
0.00%
-66.7%
Q1 2016$21,000
-22.2%
619
-61.0%
0.00%
+50.0%
Q4 2015$27,0001,5880.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders